Dodge & Cox Novartis Ag Transaction History
Dodge & Cox
- $174 Billion
- Q3 2025
A detailed history of Dodge & Cox transactions in Novartis Ag stock. As of the latest transaction made, Dodge & Cox holds 10,585,145 shares of NVS stock, worth $1.39 Billion. This represents 0.78% of its overall portfolio holdings.
Number of Shares
10,585,145
Previous 10,647,629
0.59%
Holding current value
$1.39 Billion
Previous $1.29 Billion
5.35%
% of portfolio
0.78%
Previous 0.78%
Shares
33 transactions
Others Institutions Holding NVS
# of Institutions
1,603Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
-
Loomis Sayles & CO L P5.66MShares$745 Million0.89% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...